Deciphera Pharmaceuticals, Inc. Lease Obligation Incurred
Deciphera Pharmaceuticals, Inc. reported Lease Obligation Incurred of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2021-02-09
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for the quarter ending 2018-12-31 was $311.00K.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for the quarter ending 2018-09-30 was -$5.45M.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for fiscal 2020 was $0.00.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for fiscal 2018 was $11.88M.
- Deciphera Pharmaceuticals, Inc. lease obligation incurred for fiscal 2017 was $0.00.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 9 month as first filed | Lease Obligation Incurred 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-09 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $0.00 10-K · filed 2021-02-09 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-04 | ||||
| 2018-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$5.14M derived: sum of 2 quarters · filed 2021-02-09 | $11.88M 10-K · filed 2021-02-09 | ||
| 2018-09-30 | -$5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $11.57M 10-Q · filed 2019-11-04 | $17.87M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $17.03M 10-Q · filed 2019-08-02 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 |